CIC-1 inhibitor therapy(NMD Pharma)

N/A

Report date: 2023/11/24 16:03:17

Base Information

Drug NameCIC-1 inhibitor therapy(NMD Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChloride channel protein 1 inhibitors
TargetsChloride channel protein 1
Therapy Area/IndicationsNeuromuscular BlockadeNeuromuscular DiseasesSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNMD Pharma AS
China Registration ClassN/A

Develop Information

Active CompaniesNMD Pharma AS
Inactive CompaniesN/A
Active IndicationsNeuromuscular BlockadeNeuromuscular DiseasesSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A